Health Catalyst (HCAT) Stock: Buy, Sell, or Hold?
HCAT - Health Catalyst, Inc Common Stock
$1.70
-0.03 (-1.73%)
âŧ
5d:
-2.3%
30d:
-0.58%
90d:
-18.27%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 09, 2026
Get Alerted When HCAT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: HCAT is fairly priced but lacks strong directional signals. At 80.0% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: HCAT is fairly priced but lacks strong directional signals. At 80.0% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: HCAT is currently trading at $1.70, which is considered fair relative to its 30-day fair value range of $1.64 to $1.79. From a valuation perspective, the stock is trading at a premium (Forward PE: 226.7) compared to its historical average (38.9). At these levels, the market is pricing in 80.0% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, HCAT is in a downtrend. The price is currently testing key support at $1.70. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: HCAT scores 38/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HCAT is in a downtrend. The price is currently testing key support at $1.70. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: HCAT scores 38/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.64 -
$1.79
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
40.5%
Protect Your Profits
Holding HCAT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (38/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($1.77)
- BEARISH: Market expects 80.0% growth - appears too optimistic based on history
- WARNING: Composite score 44/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.64 -
$1.79
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.70
Resistance Level
$1.89
Current Trend
Downtrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
226.67
Wall Street Target
$1.77
(+3.9%)
Revenue Growth (YoY)
-12.7%
Profit Margin
-90.6%
Valuation Premium vs History
+80.0% premium
PE vs Historical
226.7 vs 38.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+80.0%
(market-implied from PE analysis)
1-Year Target
$2.55
(+50%)
2-Year Target
$3.83
(+125%)
3-Year Target
$5.74
(+238%)
3-Yr Target (if PE normalizes)
(PE: 227â39)
PE COMPRESSION
$0.98
(-42%)
Significant PE compression expected
Share & Embed Analysis
Last updated: October 02, 2026 6:05 AM ET
Data refreshes hourly during market hours. Next update: 7:05 AM
Data refreshes hourly during market hours. Next update: 7:05 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HCAT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 60 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 80 BUY |
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$297 | 41 HOLD |
|
GEHC
GE HealthCare TechnologiâĻ |
STRONG BUY
21 analysts |
$90 | 56 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 51 HOLD |
Advanced HCAT Option Strategies
Professional options setups generated by AI based on today's HCAT price and gamma walls.
